文献速递心脑血管急症重症综合管理与镇静镇痛

经皮耳迷走神经刺激减轻小鼠创伤性脑损伤模型的神经炎症

Transcutaneous auricular vagus nerve stimulation attenuates neuroinflammation in a mouse model of traumatic brain injury.
PubMed 文献 · J Trauma Acute Care Surg · 2025-12-17
一句话结论小鼠创伤性脑损伤模型中,经皮耳迷走神经刺激激活孤束核与迷走神经背运动核,降低伤侧皮质促炎标志物并升高抗炎标志物。

研究采用小鼠控制性皮质撞击模型,分设假手术野生型、创伤性脑损伤野生型、假刺激和创伤性脑损伤加经皮耳迷走神经刺激四组,动物麻醉后接受30分钟离位刺激或经皮耳迷走神经刺激,短期组和长期组分别接受两次治疗并于伤后第3天和第7天检测。经皮耳迷走神经刺激上调孤束核和迷走神经背运动核的神经元活化标志物c-Fos,提示迷走神经被激活。伤后第3天和第7天,伤侧皮质促炎小胶质细胞标志物Tnf(1.69 ± 0.17 vs. 3.615 ± 0.86,p < 0.05)和Lcn2(64.15 ± 14 vs. 337.7 ± 104.8,p < 0.01)表达降低。伤后第3天抗炎小胶质细胞标志物Arg1(55 ± 6.47 vs. 30.49 ± 3.94,p < 0.01)和星形胶质细胞Gfap反应性(8,582 ± 826 vs. 4,569 ± 554.3,p < 0.01)表达升高。

要点

  • 小鼠创伤性脑损伤模型中,经皮耳迷走神经刺激30分钟、两次治疗,伤后第3天和第7天伤侧皮质Tnf和Lcn2表达较未刺激组降低。
  • 经皮耳迷走神经刺激组伤后第3天Arg1和Gfap表达较未刺激组升高,提示小胶质细胞向抗炎表型偏移及星形胶质细胞反应性增强。
  • 经皮耳迷走神经刺激后孤束核和迷走神经背运动核c-Fos显著上调,证实该刺激方式可激活迷走神经通路。
  • 研究为小鼠控制性皮质撞击模型,结果不能直接推导至急诊或ICU创伤性脑损伤患者的临床决策。

适用人群与场景

  • C57BL/6野生型小鼠,采用控制性皮质撞击模型制造创伤性脑损伤。
  • 实验分组包括假手术野生型、创伤性脑损伤野生型、假刺激和创伤性脑损伤加经皮耳迷走神经刺激四组。

处置流程与药物剂量

  • 动物麻醉后接受离位刺激或经皮耳迷走神经刺激30分钟;短期组和长期组分别接受两次经皮耳迷走神经刺激治疗,并分别于伤后第3天和第7天检测。

研究设计与关键结果

  • 研究类型为小鼠控制性皮质撞击模型实验,比较假手术野生型、创伤性脑损伤野生型、假刺激和创伤性脑损伤加经皮耳迷走神经刺激四组,于伤后第3天和第7天检测。
  • 经皮耳迷走神经刺激激活孤束核和迷走神经背运动核,神经元活化标志物c-Fos显著上调。
  • 伤后第3天伤侧皮质促炎小胶质细胞标志物Tnf表达:经皮耳迷走神经刺激组1.69 ± 0.17 vs. 未刺激组3.615 ± 0.86,p < 0.05。
  • 伤后第7天伤侧皮质促炎小胶质细胞标志物Lcn2表达:经皮耳迷走神经刺激组64.15 ± 14 vs. 未刺激组337.7 ± 104.8,p < 0.01。
  • 伤后第3天抗炎小胶质细胞标志物Arg1表达:经皮耳迷走神经刺激组55 ± 6.47 vs. 未刺激组30.49 ± 3.94,p < 0.01。
  • 伤后第3天星形胶质细胞Gfap反应性:经皮耳迷走神经刺激组8,582 ± 826 vs. 未刺激组4,569 ± 554.3,p < 0.01。

证据类型、等级与局限

  • 证据类型:小鼠控制性皮质撞击模型实验。
  • 统计方法采用Student t检验和单因素方差分析,p < 0.05为差异有统计学意义。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文为小鼠创伤性脑损伤模型实验,未给出急诊或ICU临床应用建议。
  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. Although TBI pathophysiology has been thoroughly investigated, the effectivity of therapeutic approaches for TBI is still lacking. Our group has developed a novel approach of noninvasive transcutaneous auricular vagus nerve stimulation (taVNS) in a mouse model of TBI to investigate its impact on neuroinflammation.

METHODS: A murine-controlled cortical impact model was used, and results were analyzed on postinjury days (PIDs) 3 and 7. The experimental groups included (1) sham C57BL/6 wild type (WT), (2) TBI wild type, (3) sham-taVNS, and (4) TBI-taVNS. The animals underwent anesthesia, off-site stimulation, or taVNS for 30 minutes. The short- and long-term groups received two sessions of taVNS treatment and were tested on PIDs 3 and 7, respectively. A combination of real-time polymerase chain reaction and immunohistochemistry was used to validate the success of the model and to quantify gene expression associated with microglial and astrocyte activation. Student's t test and one-way analysis of variance were used for statistical analysis, with significance achieved when p < 0.05.

RESULTS: Transcutaneous auricular vagus nerve stimulation (VNS) activated the solitary tract nucleus and the dorsal motor nucleus of the vagus nerve as evidenced by a significant upregulation of the neuronal activation marker c-Fos, indicating vagus nerve activation. Transcutaneous auricular VNS treatment reduced the expression of pro-inflammatory microglial markers Tnf (1.69 ± 0.17 vs. 3.615 ± 0.86, p < 0.05) and Lcn2 (64.15 ± 14 vs. 337.7 ± 104.8, p < 0.01) in the ipsilateral injured cortex on PIDs 3 and 7, respectively. Transcutaneous auricular VNS also increased the expression of anti-inflammatory microglial marker Arg1 (55 ± 6.47 vs. 30.49 ± 3.94, p < 0.01) and astrocyte Gfap reactivity (8,582 ± 826 vs. 4,569 ± 554.3, p < 0.01) on PID 3. ( J Trauma Acute Care Surg . 2026;100: 707-713. Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.).

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. El Baassiri MG, Lawandos L, Scheese D, et al. Transcutaneous auricular vagus nerve stimulation attenuates neuroinflammation in a mouse model of traumatic brain injury. J Trauma Acute Care Surg. 2025. PMID: 41417669. doi:10.1097/TA.0000000000004849

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。